Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-11-20

Clinical Trial Update: Study of Vanadium Supplement in Patients With Impaired Glucose Tolerance [Phase 3]

View source ↗

Summary

This update notes the completion of a Phase 3 clinical trial evaluating a vanadium supplement in adults with impaired glucose tolerance (prediabetes).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vanadium supplement (vanadium)

Snippet

Sponsor: Unidad de Investigacion Medica en Epidemiologia Clinica | Conditions: Prediabetic State | Phase 3 | Status: COMPLETED